Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

International Journal of Antimicrobial Agents

Volumn 40, Issue SUPPL. 1, 2012, Pages

  Lu, Po Liang ^a,n   Liu, Yung Ching ^b,o   Toh, Han Siong ^c   Lee, Yu Lin ^d,p   Liu, Yuag Meng ^d,e   Ho, Cheng Mao ^e,f,h   Huang, Chi Chang ^g   Liu, Chun Eng ^d   Ko, Wen Chien ^g,q   Wang, Jen Hsien ^h   Tang, Hung Jen ^c   Yu, Kwok Woon ^i,r   Chen, Yao Shen ^j,p,s   Chuang, Yin Ching ^c   Xu, Yingchun ^k   Ni, Yuxing ^l   Chen, Yen Hsu ^a,n   Hsueh, Po Ren ^m  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f Division of Infectious Diseases   (Taiwan)

^g NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^h CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁱ CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^j KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^k PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^l SHANGHAI JIAO TONG UNIVERSITY   (China)

^m NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

ⁿ KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^o TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^p NATIONAL YANG MING UNIVERSITY   (Taiwan)

^q NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^r TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^s NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

more..

Author keywords

Asia Pacific region; Carbapenems; Extended spectrum lactamase (ESBL); Fluoroquinolone resistance; Interpretive susceptibility criteria; SMART; Urinary tract infections

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; URINARY TRACT INFECTION;

AMIKACIN; ANTI-BACTERIAL AGENTS; ASIA; AUSTRALASIA; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; CEFTAZIDIME; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN; PREVALENCE; PROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 84863501931     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/S0924-8579(12)70008-0     Document Type: Article

References (13)

1. JW Chow, V Satishchandran, TA Snyder, CM Harvey, IR Friedland, MJ Dinubile In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART) Surg Infect (Larchmt) 6 2005 439 448
2. F Rossi, F Baquero, PR Hsueh, DL Paterson, GV Bochicchio, TA Snyder et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends) J Antimicrob Chemother 58 2006 205 210 (Pubitemid 44295010)
3. SP Hawser, SK Bouchillon, DJ Hoban, RE Badal, PR Hsueh, DL Paterson Emergence of high levels of extended-spectrum-beta-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007 Antimicrob Agents Chemother 53 2009 3280 3284
4. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. Document M100-S21 2011 CLSI Wayne, PA
5. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20 2010 CLSI Wayne, PA
6. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twenty-second informational supplement. Document M100-S22 2012 CLSI Wayne, PA
7. A Dalhoff, PG Ambrose, JW Mouton A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints Infection 37 2009 296 305
8. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard 8th edition. Document M07-A9 2008 CLSI Wayne, PA
9. PR Hsueh, DJ Hoban, Y Carmeli, SY Chen, S Desikan, M Alejandria et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region J Infect 63 2011 114 123
10. PR Hsueh, RE Badal, SP Hawser, DJ Hoban, SK Bouchillon, Y Ni et al. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends) Int J Antimicrob Agents 36 2010 408 414
11. S Meier, R Weber, R Zbinden, C Ruef, B Hasse Extended-spectrum beta-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy Infection 39 2011 333 340
12. OK Azap, H Arslan, K Serefhanoglu, S Colakoglu, H Erdogan, F Timurkaynak et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections Clin Microbiol Infect 16 2010 147 151
13. CY Lin, SH Huang, TC Chen, PL Lu, WR Lin, YH Chen Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates J Microbiol Immunol Infect 41 2008 325 331